Akouos Announces Pricing of Initial Public Offering
June 25, 2020 19:42 ET
|
Akouos, Inc.
BOSTON, June 25, 2020 (GLOBE NEWSWIRE) -- Akouos, Inc. (“Akouos”) (Nasdaq: AKUS), a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve,...